# Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

> **NCT07058051** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 100 (actual)

## Conditions studied

- Non-Segmental Vitiligo

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07058051
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-17
- **Primary completion:** 2025-11-13
- **Final completion:** 2025-11-13
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07058051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07058051, "Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07058051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*